Variant report

Variant	esv3338592
Chromosome Location	chr12:103817534-103849094
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:247)
CpG islands
(count:123)
Chromatin interactive
region (count:2)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:247 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr12:103825062-103825439	GM12878	blood:	n/a	n/a
2	ATF2	chr12:103825131-103825486	GM12878	blood:	n/a	n/a
3	ATF2	chr12:103834865-103835785	GM12878	blood:	n/a	n/a
4	ATF2	chr12:103835003-103835760	GM12878	blood:	n/a	n/a
5	BATF	chr12:103835030-103835729	GM12878	blood:	n/a	chr12:103835364-103835375
6	BATF	chr12:103835083-103835700	GM12878	blood:	n/a	chr12:103835364-103835375
7	BATF	chr12:103836632-103836965	GM12878	blood:	n/a	chr12:103836903-103836911
8	BATF	chr12:103836621-103836954	GM12878	blood:	n/a	chr12:103836903-103836911
9	BATF	chr12:103825168-103825533	GM12878	blood:	n/a	n/a
10	BATF	chr12:103825124-103825703	GM12878	blood:	n/a	n/a
11	BCL11A	chr12:103835050-103835754	GM12878	blood:	n/a	n/a
12	BCL11A	chr12:103825187-103825437	GM12878	blood:	n/a	n/a
13	BCL11A	chr12:103825162-103825545	GM12878	blood:	n/a	n/a
14	BCL11A	chr12:103835170-103835632	GM12878	blood:	n/a	n/a
15	BCL11A	chr12:103836662-103836953	GM12878	blood:	n/a	n/a
16	BCL3	chr12:103835131-103835593	GM12878	blood:	n/a	n/a
17	BCLAF1	chr12:103834994-103835773	GM12878	blood:	n/a	n/a
18	BCLAF1	chr12:103835190-103835712	GM12878	blood:	n/a	n/a
19	BCLAF1	chr12:103825038-103825545	GM12878	blood:	n/a	n/a
20	BHLHE40	chr12:103834909-103835685	GM12878	blood:	n/a	n/a
21	CEBPB	chr12:103827124-103827405	HepG2	liver:	n/a	chr12:103827237-103827248
22	CEBPB	chr12:103827115-103827352	A549	lung:	n/a	chr12:103827237-103827248
23	CEBPB	chr12:103835010-103835807	GM12878	blood:	n/a	chr12:103835099-103835110 chr12:103835099-103835110 chr12:103835032-103835044
24	CHD1	chr12:103834640-103835703	GM12878	blood:	n/a	n/a
25	CHD2	chr12:103836006-103836291	GM12878	blood:	n/a	n/a
26	CHD2	chr12:103834909-103835695	GM12878	blood:	n/a	n/a
27	CHD2	chr12:103828531-103828665	H1-hESC	embryonic stem cell:	n/a	n/a
28	CTCF	chr12:103819140-103819290	A549	lung:	n/a	n/a
29	CTCF	chr12:103824083-103824182	Kidney_OC	kidney:	n/a	n/a
30	CTCF	chr12:103828692-103828722	HepG2	liver:	n/a	n/a
31	CTCF	chr12:103819100-103819250	WERI-Rb-1	eye:	n/a	n/a
32	CTCF	chr12:103819166-103819201	HepG2	liver:	n/a	n/a
33	CTCF	chr12:103819061-103819275	MCF-7	breast:	n/a	n/a
34	CTCF	chr12:103818644-103818677	Lung_OC	lung:	n/a	n/a
35	CTCF	chr12:103835240-103835390	GM12872	blood:	n/a	n/a
36	CTCF	chr12:103819172-103819180	GM12891	blood:	n/a	n/a
37	CTCF	chr12:103819080-103819230	HEK293	kidney:	n/a	n/a
38	CTCF	chr12:103819126-103819246	H1-hESC	embryonic stem cell:	n/a	n/a
39	CTCF	chr12:103819080-103819230	WERI-Rb-1	eye:	n/a	n/a
40	CTCF	chr12:103819073-103819277	MCF-7	breast:	n/a	n/a
41	CTCF	chr12:103819120-103819270	MCF-7	breast:	n/a	n/a
42	CTCF	chr12:103835260-103835410	GM12878	blood:	n/a	n/a
43	CTCF	chr12:103835297-103835391	GM10248	blood:	n/a	n/a
44	CTCF	chr12:103835175-103835545	GM12878	blood:	n/a	n/a
45	CTCF	chr12:103828640-103828790	GM12867	blood:	n/a	n/a
46	CTCF	chr12:103819059-103819286	MCF-7	breast:	n/a	n/a
47	CTCF	chr12:103819100-103819250	HepG2	liver:	n/a	n/a
48	CTCF	chr12:103819166-103819202	A549	lung:	n/a	n/a
49	CTCF	chr12:103835332-103835382	GM12891	blood:	n/a	n/a
50	CTCF	chr12:103819038-103819242	H1-hESC	embryonic stem cell:	n/a	n/a

(count:123 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:103838906-103838956	HAEpiC	amniotic membrane:	n/a
2	chr12:103838906-103838956	HAEpiC	amniotic membrane:	n/a
3	chr12:103838906-103838956	HRPEpiC	eye:	n/a
4	chr12:103828459-103828509	HMEC	breast:	n/a
5	chr12:103838906-103838956	AG10803	skin:	n/a
6	chr12:103838906-103838956	PFSK-1	brain:	n/a
7	chr12:103828459-103828509	K562	blood:	n/a
8	chr12:103828459-103828509	HepG2	liver:	n/a
9	chr12:103838906-103838956	BJ	skin:	n/a
10	chr12:103828459-103828509	GM12892	blood:	n/a
11	chr12:103838906-103838956	ovcar-3	ovarian:	n/a
12	chr12:103838906-103838956	HCM	heart:	n/a
13	chr12:103828459-103828509	CMK	blood:	n/a
14	chr12:103828459-103828509	PrEC	prostate:	n/a
15	chr12:103828459-103828509	HCM	heart:	n/a
16	chr12:103838906-103838956	PANC-1	pancreas:	n/a
17	chr12:103828459-103828509	GM12891	blood:	n/a
18	chr12:103838906-103838956	MCF10A-Er-Src	breast:	n/a
19	chr12:103838906-103838956	HRE	kidney:	n/a
20	chr12:103828459-103828509	HEK293	kidney:	embryo
21	chr12:103838906-103838956	BE2_C	brain:	n/a
22	chr12:103838906-103838956	SK-N-MC	brain:	n/a
23	chr12:103828459-103828509	RPTEC	kidney:	n/a
24	chr12:103828459-103828509	H1-hESC	embryonic stem cell:	embryo
25	chr12:103838906-103838956	HRCEpiC	kidney:	n/a
26	chr12:103828459-103828509	NHDF-neo	bronchial:	n/a
27	chr12:103828459-103828509	HL-60	blood:	n/a
28	chr12:103828459-103828509	SK-N-SH	brain:	n/a
29	chr12:103828459-103828509	PFSK-1	brain:	n/a
30	chr12:103828459-103828509	HRE	kidney:	n/a
31	chr12:103838906-103838956	HUVEC	blood vessel:	n/a
32	chr12:103838906-103838956	HL-60	blood:	n/a
33	chr12:103838906-103838956	ECC-1	luminal epithelium:	n/a
34	chr12:103838906-103838956	LNCaP	prostate:	n/a
35	chr12:103838906-103838956	PrEC	prostate:	n/a
36	chr12:103838906-103838956	HPAEpiC	pulmonary alveolar:	n/a
37	chr12:103828459-103828509	AoSMC	blood vessel:	n/a
38	chr12:103828459-103828509	SKMC	muscle:	n/a
39	chr12:103828459-103828509	MCF10A-Er-Src	breast:	n/a
40	chr12:103838906-103838956	AG04450	lung:	fetal
41	chr12:103838906-103838956	NB4	blood:	n/a
42	chr12:103838906-103838956	HepG2	liver:	n/a
43	chr12:103828459-103828509	IMR90	lung:	fetal
44	chr12:103828459-103828509	ovcar-3	ovarian:	n/a
45	chr12:103838906-103838956	AoSMC	blood vessel:	n/a
46	chr12:103828459-103828509	HRCEpiC	kidney:	n/a
47	chr12:103828459-103828509	HCF	heart:	n/a
48	chr12:103828459-103828509	Hepatocyte	liver:	n/a
49	chr12:103828459-103828509	ProgFib	skin:	n/a
50	chr12:103828459-103828509	SAEC	small airway:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr12:103845899..103849186-chr12:103851469..103854474,4	K562	blood:
2	chr12:103826728..103828711-chr12:103887263..103890127,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PAH-2	chr12:103835246-103835373	NONHSAT030370
2	lnc-PAH-2	chr12:103835246-103835369	NONHSAT030367

No data

Variant related genes	Relation type
C12orf42	TF binding region
C12orf42	CpG island
ENSG00000179088	chromatin interactions

Extended variants
information (count: 879 )
Associated
traits (count: 67 )

Variant overlapped rSNPs/rCNVs (count:879 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs185053456	chr12:103817545-103817546	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs113817340	chr12:103817554-103817555	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs562704422	chr12:103817592-103817593	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs114450095	chr12:103817600-103817601	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs574569600	chr12:103817610-103817611	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs149913468	chr12:103817615-103817616	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs553784695	chr12:103817622-103817623	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs576889685	chr12:103817624-103817625	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs187862881	chr12:103817641-103817642	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs561197948	chr12:103817673-103817674	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs191435160	chr12:103817716-103817717	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs542114809	chr12:103817727-103817728	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs372338396	chr12:103817761-103817762	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs562286489	chr12:103817762-103817763	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs529885851	chr12:103817821-103817822	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs527847901	chr12:103817842-103817843	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs548538767	chr12:103817915-103817916	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs111933213	chr12:103817918-103817919	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs34127177	chr12:103817937-103817938	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs148656354	chr12:103817938-103817939	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs34658851	chr12:103817974-103817975	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs10860999	chr12:103818049-103818050	Enhancers Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs570041803	chr12:103818053-103818054	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs144423703	chr12:103818058-103818059	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs183631771	chr12:103818078-103818079	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs10861000	chr12:103818150-103818151	Enhancers Weak transcription Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs574792321	chr12:103818171-103818172	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs553701916	chr12:103818173-103818174	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs117547735	chr12:103818183-103818184	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs537950076	chr12:103818185-103818186	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs552522221	chr12:103818221-103818222	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs147839130	chr12:103818296-103818297	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs540665328	chr12:103818302-103818303	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs118061898	chr12:103818309-103818310	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs10745967	chr12:103818317-103818318	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs572670223	chr12:103818335-103818336	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs541578789	chr12:103818376-103818377	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs560484889	chr12:103818383-103818384	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs564506716	chr12:103818391-103818392	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs10861001	chr12:103818417-103818418	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs554870661	chr12:103818418-103818419	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs543928370	chr12:103818423-103818424	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs563811628	chr12:103818470-103818471	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs529262561	chr12:103818471-103818472	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs189904922	chr12:103818490-103818491	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs532901481	chr12:103818493-103818494	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs527577953	chr12:103818520-103818521	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs141439748	chr12:103818521-103818522	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs573196559	chr12:103818561-103818562	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs570309860	chr12:103818576-103818577	Weak transcription Strong transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:67)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung cancer	18438408	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	21390271	CNVD
Cancer	20164919	CNVD
Breast cancer	22032731	CNVD
Cancer	16751803	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Wilms tumour	21544195	CNVD
Ovarian cancer	21720365	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
lymphocytic leukemia	21291569	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16397240	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sudden cardiac death	19188705	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Neurocytoma	17123091	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21364760	CNVD
Multiple myeloma	16616336	CNVD
Myelofibrosis	22110671	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:181 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:103812800-103828800	Weak transcription	Primary B cells from cord blood	blood
2	chr12:103815800-103818200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
3	chr12:103816000-103817600	Enhancers	HUES64 Cell Line	embryonic stem cell
4	chr12:103816000-103818000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
5	chr12:103816000-103818600	Enhancers	Fetal Brain Male	brain
6	chr12:103816200-103817600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
7	chr12:103816400-103819000	Strong transcription	Primary B cells from peripheral blood	blood
8	chr12:103816800-103818200	Enhancers	Brain Germinal Matrix	brain
9	chr12:103817200-103817600	Weak transcription	Fetal Brain Female	brain
10	chr12:103817200-103818800	Enhancers	Fetal Kidney	kidney
11	chr12:103817200-103819800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
12	chr12:103817400-103818600	Weak transcription	iPS-18 Cell Line	embryonic stem cell
13	chr12:103817600-103818000	Enhancers	Fetal Brain Female	brain
14	chr12:103818400-103818600	Flanking Active TSS	A549	lung
15	chr12:103818400-103819600	Enhancers	HepG2	liver
16	chr12:103818600-103818800	Enhancers	iPS-18 Cell Line	embryonic stem cell
17	chr12:103818600-103818800	Active TSS	A549	lung
18	chr12:103819000-103820800	Weak transcription	Primary B cells from peripheral blood	blood
19	chr12:103824200-103834400	Weak transcription	Primary T cells from cord blood	blood
20	chr12:103825000-103826600	Enhancers	Primary B cells from peripheral blood	blood
21	chr12:103825200-103826000	Enhancers	GM12878-XiMat	blood
22	chr12:103825800-103827400	Enhancers	Dnd41	blood
23	chr12:103826000-103826200	Enhancers	Primary T cells fromperipheralblood	blood
24	chr12:103826200-103828000	Weak transcription	Primary T cells fromperipheralblood	blood
25	chr12:103826600-103826800	Weak transcription	Primary B cells from peripheral blood	blood
26	chr12:103826800-103827000	Strong transcription	Primary B cells from peripheral blood	blood
27	chr12:103827000-103827200	Weak transcription	Primary B cells from peripheral blood	blood
28	chr12:103827200-103827800	ZNF genes & repeats	Primary B cells from peripheral blood	blood
29	chr12:103827200-103828600	Enhancers	Primary T helper naive cells from peripheral blood	blood
30	chr12:103827400-103827800	ZNF genes & repeats	iPS-20b Cell Line	embryonic stem cell
31	chr12:103827400-103828400	Flanking Active TSS	Dnd41	blood
32	chr12:103827400-103828800	Active TSS	ES-I3 Cell Line	embryonic stem cell
33	chr12:103827600-103828200	Enhancers	H1 Cell Line	embryonic stem cell
34	chr12:103827600-103828400	Active TSS	A549	lung
35	chr12:103827600-103828800	Active TSS	HUES6 Cell Line	embryonic stem cell
36	chr12:103827800-103828600	Active TSS	iPS-20b Cell Line	embryonic stem cell
37	chr12:103827800-103828800	Enhancers	Primary T regulatory cells fromperipheralblood	blood
38	chr12:103827800-103834200	Weak transcription	Primary B cells from peripheral blood	blood
39	chr12:103828000-103828400	Enhancers	Primary T cells fromperipheralblood	blood
40	chr12:103828000-103828400	Enhancers	Primary T helper cells fromperipheralblood	blood
41	chr12:103828000-103828800	Active TSS	H9 Cell Line	embryonic stem cell
42	chr12:103828200-103828400	Flanking Active TSS	H1 Cell Line	embryonic stem cell
43	chr12:103828200-103828400	Active TSS	iPS-18 Cell Line	embryonic stem cell
44	chr12:103828200-103828600	Active TSS	iPS-15b Cell Line	embryonic stem cell
45	chr12:103828200-103828600	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr12:103828200-103828600	Active TSS	Placenta	Placenta
47	chr12:103828200-103828600	Active TSS	Rectal Mucosa Donor 31	rectum
48	chr12:103828200-103828600	Active TSS	HepG2	liver
49	chr12:103828200-103828800	Active TSS	ES-WA7 Cell Line	embryonic stem cell
50	chr12:103828200-103828800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links